本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

15.24
+0.34002.28%
盘后15.240.00000.00%19:43 EDT
成交量:75.84万
成交额:1,156.69万
市值:9.27亿
市盈率:-8.31
高:15.50
开:14.94
低:14.94
收:14.90
52周最高:35.34
52周最低:12.12
股本:6,083.17万
流通股本:4,168.06万
量比:1.03
换手率:1.82%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
净资产收益率:-11.48%
总资产收益率:-9.55%
市净率:0.97
市盈率(LYR):-8.31

数据加载中...

2024/11/05

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities